Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jul 16 2025

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the closure of a Remote Regulatory Assessment by the USFDA at its Matoda facility in Gujarat. The assessment was conducted for the Prior Approval Supplement of Atorvastatin Calcium Tablets, and no observations were noted during the review. The site has been recommended for approval following the assessment, which is significant for the company's operations.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases